伊宁市医院泌尿外科(宏康妇科怎么样啊) (今日更新中)

GAITHERSBURG, Md. -- Under the fluorescent lights, inside a series of labs, researchers believe they may have cracked the code to create a vaccine for the new coronavirus, which has officially named COVID-19.“It’s rapidly evolving,” said Dr. Gregory Glenn, president of research and development at the Maryland-based company Novavax. “As a company, we are very invested in looking at how to protect people against infectious diseases.”Novavax is one of several pharmaceutical companies around the world, racing to develop a vaccine for the strain of the coronavirus, which recently emerged in Wuhan, China.“We have to puzzle-solve with vaccines,” Dr. Glenn said. “We think about: what do we want to have the immune response to target? Because that should block the infection and stop the illness and that’s the goal here.”He showed a three-dimensional computerized depiction of what the virus looks like.“The coronavirus – corona being ‘crown’ – has spikes,” he said. “Those spikes have a very important function. They let the virus bind to the human cell and then those spikes act as a syringe to inject genetic material into the human cell.”A vaccine would potentially stop that process, thereby protecting a person from the coronavirus.“We have the gene, we have the vaccine, we’re going to move it into animal testing shortly,” Dr. Glenn said. “Our goal is in late spring to be testing in humans.”It normally takes about 18 months to get human trials started on a vaccine. This shorter time frame is nothing new for the company; they developed an Ebola vaccine within 90 days ready for testing – but there’s a catch.It can take years for a vaccine to get approved, but under dire circumstances sometimes they can be used through something called “expanded access” or “compassionate use” – meaning, the vaccine can be used in humans, before it’s fully licensed.“That happened with Ebola – they didn’t have a licensed vaccine, but they were able to use it under ‘compassionate use,’ they developed evidence that it was working,” Dr. Glenn said.As for a fully approved coronavirus vaccine, experts say that would take longer.“A vaccine in a year would be record-setting time, but not in time to probably have much impact for this disease outbreak,” said Dr. Eric Toner with the Johns Hopkins Center for Health Security.However, if the coronavirus sticks around or comes back stronger in a second wave of the disease, Dr. Glenn said they want to be ready.“We know time is of the essence here,” he said.So far, approximately 73,000 people have been infected and more than 1,800 people have died from the most recent strain of the coronavirus. 2653

If it's not the heat death of the Earth that consumes us; if we are not snuffed out by blight, famine and the volatile hubris of mankind, it's only a matter of time before the cockroaches rise up and conquer us all. They are growing stronger.They are keen to our defenses and devour them, snickering all the while at our impotent pest control burlesque. If things continue down this dark path the exterminated, in time, will become the exterminators.This fatalistic vision is brought to you by the very disturbing news that cockroaches have apparently begun to develop a cross-resistance to powerful insecticides. 625

For Afghanstan war veteran Matthew McDonell of Wisconsin, Dec. 24, 2012 will be a day that changed his life in many ways."Christmas Eve we lost one of our teammates in a fire fight," 36-year-old Army Specialist McDonell said.That teammate was Sergeant Enrique Mondragon. Following his death on Christmas day, his squadron participated in a final roll call. A traditional military salute to a fallen soldier. It's a moment that will live with McDonell forever."It kind of starts going through your head why not me."Since then, things haven't been completely the same for McDonell. Holiday's became tough to celebrate. 628

HAMBURG, N.Y. — An 11-year-old New York boy is being remembered by all who loved him as a kind, smart and healthy child. Luca Calanni of Hamburg passed away Saturday at Oishei Children’s Hospital after complications from the flu, his family says. The 263

Google is expanding its mental health screening tools.Dr. David Feinberg, the head of Google Health, calls the impact of the pandemic a perfect storm that's led to more psychological issues.“So, we're seeing a lot of people coming to Google with questions about anxiety, about depression, and even if we go pre-COVID,” said Feinberg. “We had 48 million Americans suffering from anxiety disorders. We've now seen that increase.”According to the latest information from the Census Bureau, that increase has been drastic. It found one in three Americans are showing signs of clinical depression or anxiety, or both.Here's how the new online tool works: If you Google search “anxiety,” a panel will appear on the right side of your browser. It has information on disorders and a link to “take a self-assessment.”After answering seven simple questions, you'll be given a score ranging from minimal to severe signs of anxiety.“So, there's a lot of resources for people to stay connected, to find out if they're suffering, and to get help when appropriate,” said Feinberg. Feinberg says that's the most important thing is get help if you need it.This is Google’s third 1174

来源：资阳报